Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy
- PMID: 8055158
- DOI: 10.1007/BF00195779
Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy
Abstract
The gelatinase A (72 kDa type IV collagenase) is a matrix metallo-proteinase which degrades basement membrane collagens. Various studies emphasize its role in stromal invasion of cancers, but there is some controversy about its origin. Gelatinase A was localized by immunohistochemistry using confocal microscopy in 15 human mammary carcinomas. In addition, the cells responsible for the synthesis of this enzyme were detected by in situ hybridization. Most invasive and non-invasive tumour cells were labelled by immunohistochemistry. Of particular interest was the pattern observed in some pre-invasive areas. Gelatinase A was found in fibroblasts in close contact with pre-invasive tumour clusters. Confocal observation allowed a more precise localization of gelatinase A to the periphery of tumour clusters along the basement membranes and in peritumour fibroblasts. The malignant epithelial cells were negative by immunohistochemistry in these areas. By in situ hybridization, mRNAs encoding gelatinase A were detected only in fibroblasts in close contact with pre-invasive and well differentiated tumour clusters. These findings support the hypothesis that peritumour fibroblasts produce gelatinase A and that breast cancer cells may bind this enzyme to their cell surface and/or internalize it.
Similar articles
-
Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.World J Surg. 2000 Mar;24(3):334-40. doi: 10.1007/s002689910053. World J Surg. 2000. PMID: 10658069
-
Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.Anticancer Res. 1999 Sep-Oct;19(5B):4257-64. Anticancer Res. 1999. PMID: 10628384
-
Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology.Bull Cancer. 1992;79(3):261-70. Bull Cancer. 1992. PMID: 1392165
-
Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells.Int J Cancer. 1994 Feb 1;56(3):331-6. doi: 10.1002/ijc.2910560306. Int J Cancer. 1994. PMID: 8314319
-
Matrix metalloproteinases and metastatic cancer.Biochem Soc Symp. 1998;63:295-313. Biochem Soc Symp. 1998. PMID: 9513731 Review.
Cited by
-
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.Br J Cancer. 1996 Jun;73(11):1401-8. doi: 10.1038/bjc.1996.266. Br J Cancer. 1996. PMID: 8645587 Free PMC article.
-
MMP14 Regulates Cranial Neural Crest Epithelial-to-Mesenchymal Transition and Migration.Dev Dyn. 2018 Sep;247(9):1083-1092. doi: 10.1002/dvdy.24661. Epub 2018 Sep 9. Dev Dyn. 2018. PMID: 30079980 Free PMC article.
-
Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.Cancer Biol Ther. 2013 May;14(5):417-27. doi: 10.4161/cbt.23762. Epub 2013 Feb 4. Cancer Biol Ther. 2013. PMID: 23380593 Free PMC article.
-
Matrix metalloproteinases. Novel targets for directed cancer therapy.Drugs Aging. 1997 Sep;11(3):229-44. doi: 10.2165/00002512-199711030-00006. Drugs Aging. 1997. PMID: 9303281 Review.
-
MT-MMP expression and localisation in human lung and breast cancers.Virchows Arch. 1996 Apr;428(1):29-35. doi: 10.1007/BF00192924. Virchows Arch. 1996. PMID: 8646366
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical